Viewing Study NCT07154368


Ignite Creation Date: 2025-12-24 @ 5:31 PM
Ignite Modification Date: 2026-04-05 @ 4:26 PM
Study NCT ID: NCT07154368
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-09-19
First Post: 2025-08-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: JYP0322 Versus Platinum Based Doublet Chemotherapy in ROS1 Positive Patients Previously Treated With ROS1-TKIs.
Sponsor: Guangzhou JOYO Pharma Co., Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module